Chiropractors in Penrose, CO Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Dr. Jason Williams Barritt, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1015 State Highway 115, Suite 5, Penrose, CO 81240 Phone: 719-372-7070 Fax: 719-372-0909 |
 Injury Documentation Services, Inc. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1015 State Highway 115, Suite 5, Penrose, CO 81240 Phone: 719-372-7070 Fax: 719-372-0909 |
Injury Documentation Consultants, Inc. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1015 State Highway 115, Suite 5, Penrose, CO 81240 Phone: 719-372-7070 Fax: 719-372-0909 |
 Judy Barritt, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1015 State Highway 115, Penrose, CO 81240 Phone: 719-372-6900 |
Barritt Family Chiropractic, Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1015 State Highway 115, Penrose, CO 81240 Phone: 719-372-6900 Fax: 719-372-3253 |
Accident & Health Recovery Center Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1015 State Highway 115, Penrose, CO 81240 Phone: 719-372-6900 |
News Archive
WHO issues warning about risks of research on human engineered bird flu
"The World Health Organization issued a stern warning on Friday to scientists who have engineered a highly pathogenic form of the deadly H5N1 bird flu virus, saying their work carries significant risks and must be tightly controlled," Reuters reports.
Federal panel awards almost $500 million to La. to replace New Orleans Charity Hospital
Ending one of the longest-running disputes left by Hurricane Katrina, a federal arbitration panel ruled Wednesday that Louisiana would receive $474.8 million — nearly all it had requested — to pay for the replacement of Charity Hospital in New Orleans, which has been closed since the storm.
Stemedica files IND for trial using allogeneic mesenchymal bone marrow cells in patients with ischemic stroke
Stemedica Cell Technologies, Inc. (Stemedica), a world leader in stem cell research and manufacturing, announced that it has filed an Investigative New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for a clinical trial. The trial will assess the safety, tolerability and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.
Scientists discover genetic flaw that causes facioscapulohumeral muscular dystrophy
Nearly two decades after they identified the specific genetic flaw that causes a common type of muscular dystrophy, scientists believe they have figured out how that flaw brings about the disease. The finding by an international team of researchers settles a longstanding question about the roots of facioscapulohumeral muscular dystrophy or FSHD.
Study: Depressed patients three times more likely to experience frequent chest pain
Depressed patients have more frequent chest pain even in the absence of coronary artery disease, according to results from the Emory Cardiovascular Biobank presented at ESC Congress today by Dr Salim Hayek, a cardiologist at Emory University School of Medicine in Atlanta, Georgia, US.
› Verified 5 days ago